vs. Crestor (The Pharm Voice)
Blogger Gloria Gamat writes about the cholesterol-lowering medications Crestor and Vytorin, citing a recent study that showed Vytorin to be the more effective treatment.
Zocor's Loss of Patent Protection (Patent Baristas)
Merck's Zocor is set to lose patent protection on Friday. In her entry, blogger Karlyn Schnapp discusses the impact that this change will have on Merck.